SMAD4 and pancreatic intraductal papillary-mucinous neoplasm: Although some of our cases had SMAD4 mutations limited to the invasive cancer, most of the IPMN/MCN-associated cancers lacked driver gene alterations that were associated with invasive disease, suggesting that malignant progression is not universally driven by point mutations.